Dicarbamine as a hemoprotective agent in patients with hemoblastoses treated with chemotherapy
Ivanova, O.V.
Voprosy Onkologii 58(3): 416-419
2012
ISSN/ISBN: 0507-3758 PMID: 22888661 Document Number: 657758
Document emailed within 1 workday
Related Documents
Mochalova, A.S.; Koroleva, I.A. 2013: Clinical and economic analysis of the feasibility of using Dicarbamine for the prevention of the toxic effects of antineoplastic chemotherapy Voprosy Onkologii 59(5): 637-641Nishikawa, A.; Hashimoto, H.; Takeda, M.; Kontani, K.; Miyatake, T.; Mimura, M.; Nagamatsu, M.; Yokoi, T. 2016: Retrospective analysis of the survival benefit of chemotherapy for recurrent or advanced epithelial ovarian carcinoma in patients previously treated with paclitaxel plus platinum-based chemotherapy European Journal of Gynaecological Oncology 37(4): 451-454
Moriya, K.; Shimizu, H.; Handa, S.; Sasaki, T.; Sasaki, Y.; Takahashi, H.; Nakamura, S.; Yoshida, H.; Kato, Y. 2017: Incidence of Ophthalmic Disorders in Patients Treated with the Antineoplastic Agent S-1 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(6): 501-506
Carroll, J.F.; Moskowitz, K.A.; Edwards, N.M.; Hickey, T.J.; Rose, E.A.; Budzynski, A.Z. 1996: Immunologic assessment of patients treated with bovine fibrin as a hemostatic agent Thrombosis and Haemostasis 76(6): 925-931
Bianco, V.; Rozzi, A.; Tonini, G.; Santini, D.; Magnolfi, E.; Vincenzi, B.; D'Angelillo, R.; Marchei, P. 2002: Gemcitabine as single agent chemotherapy in elderly patients with stages III-IV non-small cell lung cancer (NSCLC): a phase Ii study Anticancer Research 22(5): 3053-3056
Kaben, U.; Nowotny, P.; Günther, I.; Preussner, S.; Konrad, H.; Westphal, H.J. 1977: Mycological studies of patients with hemoblastoses Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 32(22): 618-622
Gorodetskiĭ, V.M.; Galstian, G.S.; Karazhas, N.V. 2000: Pneumocystis pneumonia in patients with hemoblastoses Terapevticheskii Arkhiv 72(7): 69-73
Villavicencio, H. 1991: Prevention of azoospermia in patients treated with chemotherapy and/or radiotherapy Medicina Clinica 97(10): 386-387
Bertucci, F.; Viens, P.; Gravis, G.; Blaise, D.; Faucher, C.; Oziel-Taoeb, S.; Bardou, V.J.; Jacquemier, J.; Delpero, J.R.; Maraninchi, D. 1999: High-dose chemotherapy with hematopoietic stem cell support in patients with advanced epithelial ovarian cancer: analysis of 67 patients treated in a single institution Anticancer Research 19(2b): 1455-1461
Broun, V.K.; Nakhimov, E.I. 1988: Index of the intensity of polychemotherapy in patients with hemoblastoses Gematologiia i Transfuziologiia 33(5): 55-57
Aihara, A.; Terasawa, M.; Furukawa, S.; Kasai, R.; Ito, T.; Ochiai, T.; Kumagai, Y.; Iida, M.; Yamazaki, S. 2012: Two cases of hyperammonemic patients treated by chemotherapy for colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(5): 839-842
Koroleva, I.A.; Vel'sher, L.Z.; Kaziulin, A.N.; Kucheriavyĭ, I.A.; Oganesian, T.S. 2010: Gastrointestinal injuries in patients with breast cancer treated with chemotherapy Voprosy Onkologii 56(2): 206-209
Brousil, J.; Foltýnová, V.; Vĕtrovcová, E.; Tichá, E. 1977: As bone marrow scintigraphy in patients treated with chemotherapy and/or radiotherapy NUKLEARMEDIZIN. Nuclear Medicine 16(2): 86-88
Shah, J.J. 2013: Incidence and management of renal adverse events in patients with relapsed and/or refractory multiple myeloma treated with single-agent carfilzomib Oncology 27 Suppl. 3: 19-23
Mazza, P.; Lauria, F.; Gherlinzoni, F.; Fiacchini, M.; Galieni, P.; Tura, S. 1984: Non Hodgkin's lymphomas: prognostic feature of 55 patients treated with MEVAP chemotherapy Haematologica 69(2): 178-187
Serrano, J.C.; Contreras, K.; Insausti, L.; Figueroa, L.; Acquatella, G. 1999: Thyroid complications in Hodgkin's disease patients treated with radiotherapy and chemotherapy Sangre 44(6): 496-497
Melichar, B.; Voboril, Z.; Cerman, J.; Melicharová, K.; Mergancová, J.; Voboril, Ré.; Jandík, P. 2006: Survival of patients with colorectal cancer liver metastases treated by regional chemotherapy Hepato-Gastroenterology 53(69): 426-434
Olawaiye, A.B.; Godoy, H.E.; Shahzad, M.M.K.; Rauh-Hain, J.A.; Lele, S.B.; Odunsi, K. 2012: Comparison of outcomes in patients treated with multi-agent regiments of cisplatin, adriamycin, and VP-16 versus carboplatin and paclitaxel for advanced and recurrent endometrial cancer European Journal of Gynaecological Oncology 33(5): 477-479
Thanakitcharu, P.; Jirajan, B. 2016: Prevalence of Hemoglobin Cycling and its Clinical Impact on Outcomes in Thai End-Stage Renal Disease Patients Treated with Hemodialysis and Erythropoiesis-Stimulating Agent Journal of the Medical Association of Thailand 99(Suppl 2): S28-S37
Sidorova, T.A.; Gerasimova, G.K.; Lepkov, S.V.; Volkova, M.A. 1992: Biochemical indicators of anthracycline sensitivity of blast cells from patients with hemoblastoses Antibiotiki i Khimioterapiia 37(5): 17-20